Grow
Building blocks for muscle — CJC-1295 (with DAC), Ipamorelin and BPC-157, three vials, each on its own schedule.
Three vials, three parts: CJC-1295 (with DAC), Ipamorelin and BPC-157 — the building blocks for muscle. CJC-1295 (with DAC) at 1000–2000mcg per dose twice weekly before bed, Ipamorelin at 200–300mcg per dose daily before bed, and BPC-157 at 250–500mcg per dose daily in the morning — for the 4, 8 or 12 weeks you choose when you start.
- Course length
- 4, 8 or 12 weeks
- Parts
- 3
- Format
- Vials
What is in it
| Part | Amount | How often | Your benefit |
|---|---|---|---|
| CJC-1295 (with DAC) | 1000–2000mcg per dose | Twice weekly | Steady GH elevation |
| Ipamorelin | 200–300mcg per dose | Daily | A nightly GH pulse |
| BPC-157 | 250–500mcg per dose | Daily | Tissue repair |
One course, not four bottles
-
Three parts, named outright
CJC-1295 (with DAC), Ipamorelin and BPC-157, each with its own stated dose. Three separate vials, named on the page before you order.
-
Two before bed, one in the morning
Ipamorelin at 200–300mcg per dose daily and CJC-1295 (with DAC) at 1000–2000mcg per dose twice weekly, both before bed; BPC-157 at 250–500mcg per dose daily in the morning.
-
A timeline you can plan around
Onset is around 14 days and the peak window runs weeks 4 to 8. 4, 8 or 12 weeks, chosen when you start, so the course ends on the date you set.
What it gives you
For the reader who scores the protocol, not the promise
Muscle is built from three inputs — raw material, a signal to use it, and tissue that can actually repair — and most protocols only supply the first. Grow is three named inputs with three stated doses: CJC-1295 (with DAC) 1000–2000mcg, Ipamorelin 200–300mcg and BPC-157 250–500mcg, on a fixed split, so the protocol is the controlled variable.
You run several variables at once and can attribute none of them. Muscle needs a signal and repaired tissue, not just protein, but the protocols you find are split across three compounds, three frequencies and a dozen dosing opinions.
- Progress you have to take on faith
- Three compounds sourced from three vendors with no shared schedule
- A stack built for protein and nothing for the signal or the repair
Grow fixes the protocol to three compounds — CJC-1295 (with DAC) at 1000–2000mcg twice a week for the steady GH elevation, Ipamorelin at 200–300mcg every night for the pulse, and BPC-157 at 250–500mcg every morning for the tissue — over 4, 8 or 12 weeks. Three stated doses, one fixed split: what changes is the output, not the protocol.
A growth protocol you can score: three named compounds, three stated doses, one fixed split — the GH axis at night, the tissue in the morning — and a measurable change by day 14 instead of a guess.
- You expect
- Wearable changes in 2 to 4 weeks
- Time to notice
- Day 14 is the first check-in. Weeks 4–8 are the peak window, so judge it on the same measurements across that window — scale, waist, lifts or the wearable trend you already track — not on a single morning.
- Effort
- Three vials, three stated doses, one fixed split: CJC-1295 (with DAC) 1000–2000mcg twice a week and Ipamorelin 200–300mcg every night, both before bed; BPC-157 250–500mcg every morning. The doses and frequencies are fixed, so the only work left is the reconstitution and the draw.
- Is the DAC conjugation intact in the finished vial, or only on the label?
- What is the endotoxin level, and is the vial sterile as filled?
- Which lab ran the testing, and is the lot number traceable?
You should not take it on this page's word. Three compounds are three things to verify — the DAC conjugation on the CJC-1295, the identity of the Ipamorelin, and the purity of the BPC-157 — and a single number does not cover all three. That is what lot-specific documentation is for, and the decision belongs on evidence you can check rather than on trust.
A fixed course, no subscription, no auto-refill, and no account between you and the next order. Stop after any draw and nothing further is charged.
How you take it
When in the day
Who it suits
When you will notice
About Grow
Three parts, supplied as vials: CJC-1295 (with DAC) at 1000–2000mcg per dose, Ipamorelin at 200–300mcg per dose, and BPC-157 at 250–500mcg per dose.
CJC-1295 (with DAC) twice weekly and Ipamorelin daily, both before bed; BPC-157 daily in the morning.
4, 8 or 12 weeks, chosen when you start. Onset is around 14 days, and the peak window runs weeks 4 to 8.
Is this for you?
Get Started Now
This kit is still being finalised. The assessment will tell you when it lands.
Read the full specification. All three compounds and both timings are in it.
Start the assessment